.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Express Scripts
Deloitte
US Department of Justice
AstraZeneca
McKesson
Fish and Richardson
Boehringer Ingelheim
Merck
Accenture

Generated: January 18, 2018

DrugPatentWatch Database Preview

Patents Expiring in May 2025

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AllosFOLOTYNpralatrexateSOLUTION;INTRAVENOUS022468-002Sep 24, 2009RXYesYes➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
AllosFOLOTYNpralatrexateSOLUTION;INTRAVENOUS022468-002Sep 24, 2009RXYesYes➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
AllosFOLOTYNpralatrexateSOLUTION;INTRAVENOUS022468-001Sep 24, 2009RXYesNo➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
AllosFOLOTYNpralatrexateSOLUTION;INTRAVENOUS022468-001Sep 24, 2009RXYesNo➤ Subscribe➤ SubscribeTREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
Boehringer IngelheimSTRIVERDI RESPIMATolodaterol hydrochlorideSPRAY, METERED;INHALATION203108-001Jul 31, 2014RXYesYes➤ Subscribe➤ SubscribeY
Boehringer IngelheimSTIOLTO RESPIMATolodaterol hydrochloride; tiotropium bromideSPRAY, METERED;INHALATION206756-001May 21, 2015RXYesYes➤ Subscribe➤ SubscribeY
Boehringer IngelheimCOMBIVENT RESPIMATalbuterol sulfate; ipratropium bromideSPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes➤ Subscribe➤ SubscribeY
Novo Nordisk IncXULTOPHY 100/3.6insulin degludec; liraglutideSOLUTION;SUBCUTANEOUS208583-001Nov 21, 2016RXYesYes➤ Subscribe➤ SubscribeYY
Novo Nordisk IncTRESIBAinsulin degludecSOLUTION;SUBCUTANEOUS203314-002Sep 25, 2015RXYesYes➤ Subscribe➤ SubscribeYY
Novo Nordisk IncTRESIBAinsulin degludecSOLUTION;SUBCUTANEOUS203314-001Sep 25, 2015RXYesNo➤ Subscribe➤ SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Dow
US Department of Justice
Citi
Moodys
Covington
Cipla
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot